Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas: Clinical article

Journal of Neurosurgery

Volumn 113, Issue 2, 2010, Pages 202-209

  Sughrue, Michael E ^a   Sanai, Nader ^a   Shangari, Gopal ^a   Parsa, Andrew T ^a   Berger, Mitchel S ^a   McDermott, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaplastic meningioma; Malignant meningioma; Recurrent meningioma

Indexed keywords

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ATAXIC APHASIA; BASILAR ARTERY; BRACHYTHERAPY; BRAIN EDEMA; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL EVALUATION; CRANIAL NEUROPATHY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HEADACHE; HEMIPARESIS; HUMAN; HYDROCEPHALUS; KAPLAN MEIER METHOD; LIQUORRHEA; MAJOR CLINICAL STUDY; MALE; MALIGNANT MENINGIOMA; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REOPERATION; SCHOOL CHILD; SEIZURE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR LOCALIZATION; VOCAL CORD PARALYSIS; WORLD HEALTH ORGANIZATION; WOUND COMPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MORBIDITY; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; REOPERATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77955633827     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.1.JNS091114     Document Type: Article

References (21)

1. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin- Hanjani S, Martuza RL, et al: Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56-60, 2009
2. Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, et al: An orthotopic skull base model of malignant meningioma. Brain Pathol 18:172-179, 2008 (Pubitemid 351430395)
3. Baia GS, Stifani S, Kimura ET, McDermott MW, Pieper RO, Lal A: Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 10:604-612, 2008 (Pubitemid 351770304)
4. Cage TA, Lamborn KR, Ware ML, Frankfurt A, Chakalian L, Berger MS, et al: Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with meningiomas. J Neurooncol 93:151-156, 2009
5. Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, et al: Molecular signatures define two main classes of meningiomas. Mol Cancer 6:64, 2007
6. Chamberlain MC, Glantz MJ, Fadul CE: Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 69:969-973, 2007
7. Chamberlain MC, Tsao-Wei DD, Groshen S: Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol 78:271-276, 2006
8. Chamberlain MC, Tsao-Wei DD, Groshen S: Temozolomide for treatment-resistant recurrent meningioma. Neurology 62: 1210-1212, 2004
9. Chun JY, McDermott MW, Lamborn KR, Wilson CB, Higashida R, Berger MS: Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas. Neurosurgery 50:1231-1237, 2002 (Pubitemid 36322763)
10. Gupta V, Su YS, Samuelson CG, Liebes LF, Chamberlain MC, Hofman FM, et al: Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas. J Neurosurg 106:455-462, 2007 (Pubitemid 46354300)
11. Hosmer DW, Lemeshow S: Applied Logistic Regression, ed 2. New York: John Wiley & Sons, 2000
12. Jääskeläinen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461-469, 1986
13. Johnson WD, Loredo LN, Slater JD: Surgery and radiotherapy: complementary tools in the management of benign intracranial tumors. Neurosurg Focus 24(5):E2, 2008
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds): WHO Classification of Tumours of the Central Nervous System, ed 4. Lyon: IARC Press, 2007
15. Mattozo CA, De Salles AA, Klement IA, Gorgulho A, McArthur D, Ford JM, et al: Stereotactic radiation treatment for recurrent nonbenign meningiomas. J Neurosurg 106:846-854, 2007 (Pubitemid 46698671)
16. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW: Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:299-307, 2008
17. Nakane Y, Natsume A, Wakabayashi T, Oi S, Ito M, Inao S, et al: Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A. J Neurosurg 107:398-404, 2007
18. Ojemann SG, Sneed PK, Larson DA, Gutin PH, Berger MS, Verhey L, et al: Radiosurgery for malignant meningioma: results in 22 patients. J Neurosurg 93 (Suppl 3):62-67, 2000
19. Sanai N, Sughrue ME, Shangari G, Chung K, Berger MS, McDermott MW: Risk profile associated with convexity meningioma resection in the modern neurosurgical era. Clinical article. J Neurosurg [epub ahead of print July 31, 2009. DOI: 10.3171/2009.6.JNS081490]
20. Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, et al: Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49:1029-1038, 2001
21. Turgut M, Ozcan OE, Benli K, Ozgen T, Gürcay O, Bertan V, et al: Factors affecting morbidity and mortality following surgical intervention in patients with intracranial meningioma. Aust N Z J Surg 66:144-150, 1996